IFNB1 and neoplasm: As we observed a consistent increase in the levels of IFN-β and IFN-γ, we next sought to characterize the functional role of these signalling molecules with the use of blocking/neutralizing antibodies in mice bearing intracranial CT-2A tumours and treated with SMC and anti-PD-1.